Wellbeing at Work Blog Featuring Coriell Life Sciences
Since DNA doesn’t change, a one-time genetic test for medication safety provides insight that can be used to inform optimal prescription choices throughout an employee’s life.
Since DNA doesn’t change, a one-time genetic test for medication safety provides insight that can be used to inform optimal prescription choices throughout an employee’s life.
Coriell Life Sciences’ Medication Safety Program participant testimonials.
CLS brings a new facet of insight about individual patients to clinicians to make better medication choices.
By empowering employees – and their providers – with a clear view of which medications are the safest and most effective for them specifically, doctors and pharmacists can better personalize treatment plans for mental health as well as other conditions.
Coriell Life Sciences’ Scott Megill talks about how pharmacogenomics and how it relates to improving mental health care.
Coriell Life Sciences’ Scott Megill talks about how pharmacogenomics and how it relates to improving mental health care.
CLS relies on precision medicine to improve medication impact, reduce adverse drug events, and tailor treatment based on DNA.
LLD PGx evidence base incorporated into existing commercial decision support tools and clinical pharmacogenetic guidelines.